EPSTEIN-BARR VIRUS INFECTIONS

Clinical trials for EPSTEIN-BARR VIRUS INFECTIONS explained in plain language.

Never miss a new study

Get alerted when new EPSTEIN-BARR VIRUS INFECTIONS trials appear

Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Immune drug trial offers hope for Tough-to-Treat Virus-Linked cancers

Disease control Recruiting now

This study is testing the drug nivolumab to see if it can slow or stop the growth of certain cancers linked to the Epstein-Barr virus (EBV). It is for people aged 12 and older with EBV-positive lymphomas or lymphoproliferative disorders who have no standard therapy options or who…

Matched conditions: EPSTEIN-BARR VIRUS INFECTIONS

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

EPSTEIN-BARR VIRUS INFECTIONS

Get alerted when new EPSTEIN-BARR VIRUS INFECTIONS trials appear

Immune drug trial offers hope for Tough-to-Treat Virus-Linked cancers